Health Point Inc. Angiogenesis Research Progressing Rapidly
Studies recently published by Health Point Inc. have attracted the attention of several research foundations which have provided access to additional resources and partnerships.
418 Kwun Tong Rd Central, Hong Kong, China, November 26, 2014 (Newswire.com) - The most significant study evidenced a direct co-relation between stem cell research to produce and stimulate new capillaries, a process known as angiogenesis. The work was founded on early research by the company which focused on the study of advancing treatment of chronic lower limb ischemia.
Health Point Inc. plans further expansion to research facilities to increase the understanding of this ground breaking mechanism. Laboratory and staffing Expansion will be funded via proceeds of the upcoming IPO in early 2015.
Health Point Inc. (HPI) is a privately-owned company specializing in the development, manufacture and supply of stem cells for basic research and therapeutic development for the treatment of various diseases and conditions. The company utilizes what it calls Creative (stem cell-based) technology and other developed proprietary methods in the field of regenerative medicine that would enable drug discovery and life-changing therapies. More information can be found at healthpointincorporated.com.
Health Point Inc. is committed to deliver safe, effective and affordable stem cell therapies in a bench-to-bed approach, by nurturing cutting-edge research and clinical applications and by matching customer satisfaction in attaining the rejuvenating hope. Health Point Inc. strives to maintain scientific and ethical practices through a Quality Management System in accordance with accepted national and international norms. Health Point Inc. will accomplish this through dedicated efforts of its team to continually monitor and improve the effectiveness of the Quality Management System to excel and innovate thereby reflecting that we are truly pro-Life.
The information contained in this release is provided on an errors and omissions excepted basis. No statements contained within are to be construed as an offer for sale of share capital or any other offer contrary to securities law. Information is current at time of publishing. Health Point Inc. cannot be held responsible for out of date or changing information. It is the responsibility of the reader to seek out up to date company information at healthpointincorporated.com and other sources before making any material decisions.